Roivant Sciences Ltd
ROIV
Market Cap$8.89B
Close$
$-3.44
131.2% downside
Current Fair Value
131.2% downsideOvervalued by 131.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.89 Billion |
|---|---|
| Enterprise Value | $2.72 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $5.73 |
| Beta | 0.0 |
| Outstanding Shares | 805,846,006 |
| Avg 30 Day Volume | 6,767,741 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 1.99 |
|---|---|
| PEG | -0.13 |
| Price to Sales | - |
| Price to Book Ratio | 1.58 |
| Enterprise Value to Revenue | 22.11 |
| Enterprise Value to EBIT | -2.6 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
ESG Score
No data